S.A. Mason LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
S.A. Mason LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$61,0130.0%9250.0%0.04%0.0%
Q1 2023$61,013
-50.0%
925
-60.8%
0.04%
-52.2%
Q4 2022$122,036
-24.2%
2,3600.0%0.09%
-27.6%
Q3 2022$161,000
+12.6%
2,360
-25.3%
0.13%
+22.1%
Q2 2022$143,000
+2.9%
3,160
+15.1%
0.10%
+19.5%
Q1 2022$139,000
-29.1%
2,745
-33.9%
0.09%
-26.3%
Q4 2021$196,000
+43.1%
4,1550.0%0.12%
+31.1%
Q3 2021$137,000
+204.4%
4,155
+485.2%
0.09%
+190.3%
Q2 2021$45,0007100.03%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders